Targeted Therapy Medications
Targeted therapy, a type of precision medicine, works against cancer with specific gene mutations or other unique characteristics. Researchers have identified hundreds of driver mutations that contribute cancer progression and are developing medications to block their activity. Usually this type of treatment interferes with processes required for cancer cells to grow and spread.
*generic or biosimilar available
E experimental
DRUG Adcetris |
---|
|
GENERIC NAME brentuximab vedotin |
COMPANY Seattle Genetics |
DRUG Afinitor* |
---|
|
GENERIC NAME everolimus |
COMPANY Novartis |
DRUG Alecensa |
---|
|
GENERIC NAME alectinib |
COMPANY Genentech |
DRUG Aliqopa |
---|
|
GENERIC NAME copanlisib |
COMPANY Bayer |
DRUG Alunbrig |
---|
|
GENERIC NAME brigatinib |
COMPANY Takeda |
DRUG Arzerra |
---|
|
GENERIC NAME ofatumumab |
COMPANY Novartis |
DRUG Avastin* |
---|
|
GENERIC NAME bevacizumab |
COMPANY Genentech |
DRUG Ayvakit |
---|
|
GENERIC NAME avapritinib |
COMPANY Blueprint Medicines |
DRUG Balversa |
---|
|
GENERIC NAME erdafitinib |
COMPANY Janssen |
DRUG Besponsa |
---|
|
GENERIC NAME inotuzuma ozogamicin |
COMPANY Wyeth-Pfizer |
DRUG Blenrep |
---|
|
GENERIC NAME belantamab mafodotin |
COMPANY GlaxoSmithKline |
DRUG Blincyto |
---|
|
GENERIC NAME blinatumomab |
COMPANY Amgen |
DRUG Bosulif |
---|
|
GENERIC NAME bosutinib |
COMPANY Pfizer |
DRUG Braftovi |
---|
|
GENERIC NAME encorafenib |
COMPANY Array BioPharma/Pfizer |
DRUG Brukinsa |
---|
|
GENERIC NAME zanubrutinib |
COMPANY BeiGene |
DRUG Cabometyx |
---|
|
GENERIC NAME cabozantinib |
COMPANY Exelixis |
DRUG Calquence |
---|
|
GENERIC NAME acalabrutinib |
COMPANY AstraZeneca |
DRUG Campath* |
---|
|
GENERIC NAME alemtuzumab |
COMPANY Berlex |
DRUG Copiktra |
---|
|
GENERIC NAME duvelisib |
COMPANY Verastem |
DRUG Cotellic |
---|
|
GENERIC NAME cobimetinib |
COMPANY Genentech |
DRUG Cyramza |
---|
|
GENERIC NAME ramucirumab |
COMPANY Eli Lilly |
DRUG Danyelza |
---|
|
GENERIC NAME naxitamab |
COMPANY Y-mAbs Therapeutics |
DRUG Darzalex, Darzalex Faspro |
---|
|
GENERIC NAME daratumumab |
COMPANY Janssen Therapeutics |
DRUG Daurismo |
---|
|
GENERIC NAME glasdegib |
COMPANY Pfizer |
DRUG Elzonris |
---|
|
GENERIC NAME tagraxofusp-erzs |
COMPANY Stemline Therapeutics |
DRUG Empliciti |
---|
|
GENERIC NAME elotuzumab |
COMPANY Bristol-Myers Squibb |
DRUG Enhertu |
---|
|
GENERIC NAME fam-trastuzumab deruxtecan-nxki |
COMPANY Daiichi Sankyo/AstraZeneca |
DRUG Erbitux |
---|
|
GENERIC NAME cetuximab |
COMPANY Eli Lilly |
DRUG Fotivda |
---|
|
GENERIC NAME tivozanib |
COMPANY Aveo Oncology |
DRUG Gavreto |
---|
|
GENERIC NAME pralsetinib |
COMPANY Blueprint/Genentech |
DRUG Gazyva |
---|
|
GENERIC NAME obinutuzumab |
COMPANY Genentech |
DRUG Gilotrif |
---|
|
GENERIC NAME afatinib |
COMPANY Boehringer Ingelheim |
DRUG Gleevec* |
---|
|
GENERIC NAME imatinib |
COMPANY Novartis |
DRUG Herceptin* |
---|
|
GENERIC NAME trastuzumab |
COMPANY Genentech |
DRUG Ibrance |
---|
|
GENERIC NAME palbociclib |
COMPANY Pfizer |
DRUG Iclusig |
---|
|
GENERIC NAME ponatinib |
COMPANY Pfizer |
DRUG Idhifa |
---|
|
GENERIC NAME enasidenib |
COMPANY Celgene-Agios |
DRUG Imbruvica |
---|
|
GENERIC NAME ibrutinib |
COMPANY Janssen |
DRUG Inlyta |
---|
|
GENERIC NAME axitinib |
COMPANY Pfizer |
DRUG Iressa |
---|
|
GENERIC NAME gefitinib |
COMPANY AstraZeneca |
DRUG Kadcyla |
---|
|
GENERIC NAME ado-trastuzumab emtansine |
COMPANY Genentech |
DRUG Kisqali |
---|
|
GENERIC NAME ribociclib |
COMPANY Novartis |
DRUG Koselugo |
---|
|
GENERIC NAME selumetinib |
COMPANY AstraZeneca |
DRUG Kyprolis |
---|
|
GENERIC NAME carfilzomib |
COMPANY Amgen |
DRUG Lenvima |
---|
|
GENERIC NAME lenvatinib |
COMPANY Eisai |
DRUG Lorbrena |
---|
|
GENERIC NAME lorlatinib |
COMPANY Pfizer |
DRUG Lumoxiti |
---|
|
GENERIC NAME moxetumomab pasudotox |
COMPANY AstraZeneca |
DRUG Lynparza |
---|
|
GENERIC NAME olaparib |
COMPANY AstraZeneca |
DRUG Margenza |
---|
|
GENERIC NAME margetuximab |
COMPANY MacroGenics |
DRUG Mekinist |
---|
|
GENERIC NAME trametinib |
COMPANY Novartis |
DRUG Mektovi |
---|
|
GENERIC NAME binimetinib |
COMPANY Pfizer |
DRUG Monjuvi |
---|
|
GENERIC NAME tafasitamab |
COMPANY Morphosis/Incyte |
DRUG Mylotarg |
---|
|
GENERIC NAME gemtuzumab ozogamicin |
COMPANY Pfizer/Wyeth |
DRUG Nerlynx |
---|
|
GENERIC NAME neratinib |
COMPANY Puma |
DRUG Nexavar |
---|
|
GENERIC NAME sorafenib |
COMPANY Bayer |
DRUG Ninlaro |
---|
|
GENERIC NAME ixazomib |
COMPANY Takeda |
DRUG Padcev |
---|
|
GENERIC NAME enfortumab vedotin-ejfv |
COMPANY Astellas/Seattle Genetics |
DRUG Pemazyre |
---|
|
GENERIC NAME pemigatinib |
COMPANY Incyte |
DRUG Perjeta |
---|
|
GENERIC NAME pertuzumab |
COMPANY Genentech |
DRUG Phesgo |
---|
|
GENERIC NAME Pertuzumab/trastuzumab/hyaluronidase |
COMPANY Genentech |
DRUG Piqray |
---|
|
GENERIC NAME alpelisib |
COMPANY Novartis |
DRUG Polivy |
---|
|
GENERIC NAME polatuzumab vedotin-piiq |
COMPANY Genentech |
DRUG Portrazza |
---|
|
GENERIC NAME necitumumab |
COMPANY Eli Lilly |
DRUG Qinlock |
---|
|
GENERIC NAME ripretinib |
COMPANY Deciphera |
DRUG Retevmo |
---|
|
GENERIC NAME selpercatinib |
COMPANY Eli Lilly and Company |
DRUG Rituxan* |
---|
|
GENERIC NAME rituxumab |
COMPANY Genentech |
DRUG Rozlytrek |
---|
|
GENERIC NAME entrectinib |
COMPANY Roche/Genentech |
DRUG Rubraca |
---|
|
GENERIC NAME rucaparib |
COMPANY Clovis Oncology |
DRUG Rydapt |
---|
|
GENERIC NAME midostaurin |
COMPANY Novartis |
DRUG Sarclisa |
---|
|
GENERIC NAME isatuximab-irfc |
COMPANY Sanofi-Aventis |
DRUG Sprycel |
---|
|
GENERIC NAME dasatinib |
COMPANY Bristol-Myers Squibb |
DRUG Stivarga |
---|
|
GENERIC NAME regorafenib |
COMPANY Bayer |
DRUG Sutent |
---|
|
GENERIC NAME sunitib |
COMPANY Pfizer |
DRUG Tabrecta |
---|
|
GENERIC NAME capmatinib |
COMPANY Novartis |
DRUG Tafinlar |
---|
|
GENERIC NAME dabrafenib |
COMPANY Novartis |
DRUG Tagrisso |
---|
|
GENERIC NAME osimertinib |
COMPANY AstraZeneca |
DRUG Talzenna |
---|
|
GENERIC NAME talazoparib |
COMPANY Pfizer |
DRUG Tarceva |
---|
|
GENERIC NAME erlotinib |
COMPANY Genentech/Astellas |
DRUG Tasigna |
---|
|
GENERIC NAME nilotinib |
COMPANY Novartis |
DRUG Tazverik |
---|
|
GENERIC NAME tazemetostat |
COMPANY Epizyme |
DRUG Tibsovo |
---|
|
GENERIC NAME ivosidenib |
COMPANY Agios |
DRUG Torisel |
---|
|
GENERIC NAME temsirolimus |
COMPANY Pfizer/Wyeth |
DRUG Trodelvy |
---|
|
GENERIC NAME sacituzumab govitecan |
COMPANY Immunomedics |
DRUG Tukysa |
---|
|
GENERIC NAME tucatinib |
COMPANY Seattle Genetics |
DRUG Turalio |
---|
|
GENERIC NAME pexidartinib |
COMPANY Daiichi Sankyo |
DRUG Tykerb |
---|
|
GENERIC NAME lapatanib |
COMPANY Novartis |
DRUG Vectibix |
---|
|
GENERIC NAME panitumumab |
COMPANY Amgen |
DRUG Velcade |
---|
|
GENERIC NAME bortezomib |
COMPANY Takeda |
DRUG Venclexta |
---|
|
GENERIC NAME venetoclax |
COMPANY AbbVie-Genentech |
DRUG Verzenio |
---|
|
GENERIC NAME abemaciclib |
COMPANY Eli Lilly |
DRUG Vitrakvi |
---|
|
GENERIC NAME larotrectinib |
COMPANY Bayer |
DRUG Vizimpro |
---|
|
GENERIC NAME dacomitinib |
COMPANY Pfizer |
DRUG Votrient |
---|
|
GENERIC NAME pazopanib |
COMPANY Novartis |
DRUG Xalkori |
---|
|
GENERIC NAME crizotinib |
COMPANY Pfizer |
DRUG Xospata |
---|
|
GENERIC NAME gilteritinib |
COMPANY Astellas |
DRUG Zaltrap |
---|
|
GENERIC NAME ziv-aflibercept |
COMPANY Sanofi/Genzyme |
DRUG Zejula |
---|
|
GENERIC NAME niraparib |
COMPANY Tesaro |
DRUG Zelboraf |
---|
|
GENERIC NAME vemurafenib |
COMPANY Genentech |
DRUG Zydelig |
---|
|
GENERIC NAME idelalisib |
COMPANY Gilead Sciences |
DRUG Zykadia |
---|
|
GENERIC NAME ceritinib |
COMPANY Novartis |